Experimental transfusion of variant CJD-infected blood reveals previously uncharacterised prion disorder in mice and

Emmanuel E Comoy1, Jacqueline Mikol2, Nina Jaffré2,3

  • 1CEA, Institut François Jacob, Université Paris-Saclay, 18 Route du Panorama, 92265, Fontenay-aux-Roses, France. emmanuel.comoy@cea.fr.

Nature Communications
|November 4, 2017
PubMed

Insights

Blood transfusions may transmit hidden prion diseases beyond variant Creutzfeldt-Jakob disease (vCJD). Experimental evidence in primates and mice shows masked prion variants can cause neurological impairments and spread via the intravenous route.

Area of Science:

  • Neuroscience
  • Infectious Diseases
  • Biomedical Research

Background:

  • Bovine spongiform encephalopathy (BSE) exposure caused <250 variant Creutzfeldt-Jakob disease (vCJD) cases.
  • Over 99% of vCJD infections may be silent, posing a long-term blood-borne transmission risk.

Purpose of the Study:

  • To investigate the potential for blood products to transmit prion diseases beyond vCJD.
  • To explore the mechanisms of prion propagation via the intravenous route.

Main Methods:

  • Transfusion of blood products from symptomatic and asymptomatic infected donors to mice and non-human primates.
  • Retransmission studies in mice to assess induced neurological impairments.
  • Analysis of prion protein accumulation.

Main Results:

  • Transfusion induced vCJD and a novel class of neurological impairments.
  • These new impairments were retransmissible and characterized by abnormal prion protein accumulation.
  • Findings suggest masked prion variants propagate via distinct peripheral replication mechanisms.

Conclusions:

  • The intravenous route facilitates the spread of masked prion variants.
  • Prion diseases present a broader spectrum of neurological impairments than previously recognized.
  • Blood transfusion poses a significant risk for transmitting novel prion-related neurological disorders.

Related Concept Videos